Cytoflavin in Combination With Reperfusion in Stroke Patients

NCT05297851 · clinicaltrials.gov ↗

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Stroke

Interventions

DRUG: Cytoflavin (succinic acid + inosine + nicotinamide + riboflavin)
DRUG: Control

Sponsor

POLYSAN Scientific & Technological Pharmaceutical Company